The global Azithromycin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Tablet accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Azithromycin API leading manufacturers including Shanghai Shyndec Pharmaceutical, Guobang Pharma, CSPC Pharmaceutical Group, Nexchem Pharmaceutical, HEC Pharma, Ningxia Qiyuan Pharmaceutical, Teva, Atom Pharma, Century Pharmaceuticals, Anuh Pharma Ltd, etc., dominate supply; the top five capture approximately % of global revenue, with Shanghai Shyndec Pharmaceutical leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Azithromycin API market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Azithromycin API Market Report

Report Metric	Details
Report Name	Azithromycin API Market
Segment by Type	Azithromycin Dihydrate Azithromycin Monohydrate
Segment by Application	Tablet Injection Other
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shanghai Shyndec Pharmaceutical, Guobang Pharma, CSPC Pharmaceutical Group, Nexchem Pharmaceutical, HEC Pharma, Ningxia Qiyuan Pharmaceutical, Teva, Atom Pharma, Century Pharmaceuticals, Anuh Pharma Ltd, Jubilant Pharmova Limite, Vadsp Pharmaceuticals, Mehta Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Azithromycin API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Azithromycin API Market report?

Ans: The main players in the Azithromycin API Market are Shanghai Shyndec Pharmaceutical, Guobang Pharma, CSPC Pharmaceutical Group, Nexchem Pharmaceutical, HEC Pharma, Ningxia Qiyuan Pharmaceutical, Teva, Atom Pharma, Century Pharmaceuticals, Anuh Pharma Ltd, Jubilant Pharmova Limite, Vadsp Pharmaceuticals, Mehta Pharmaceutical

What are the Application segmentation covered in the Azithromycin API Market report?

Ans: The Applications covered in the Azithromycin API Market report are Tablet, Injection, Other

What are the Type segmentation covered in the Azithromycin API Market report?

Ans: The Types covered in the Azithromycin API Market report are Azithromycin Dihydrate, Azithromycin Monohydrate

1 Study Coverage

1.1 Introduction to Azithromycin API: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Azithromycin API Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Azithromycin Dihydrate

1.2.3 Azithromycin Monohydrate

1.3 Market Segmentation by Application

1.3.1 Global Azithromycin API Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Tablet

1.3.3 Injection

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Azithromycin API Revenue Estimates and Forecasts 2020-2031

2.2 Global Azithromycin API Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Azithromycin API Sales Estimates and Forecasts 2020-2031

2.4 Global Azithromycin API Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Azithromycin API Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Azithromycin API Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Azithromycin API Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Azithromycin Dihydrate Market Size by Manufacturers

4.5.2 Azithromycin Monohydrate Market Size by Manufacturers

4.6 Global Azithromycin API Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Azithromycin API Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Azithromycin API Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Azithromycin API Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Azithromycin API Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Azithromycin API Sales and Revenue by Type (2020-2031)

7.4 North America Azithromycin API Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Azithromycin API Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Azithromycin API Sales and Revenue by Type (2020-2031)

8.4 Europe Azithromycin API Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Azithromycin API Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Azithromycin API Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Azithromycin API Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Azithromycin API Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Azithromycin API Sales and Revenue by Type (2020-2031)

10.4 Central and South America Azithromycin API Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Azithromycin API Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Azithromycin API Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Azithromycin API Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Azithromycin API Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Shanghai Shyndec Pharmaceutical

12.1.1 Shanghai Shyndec Pharmaceutical Corporation Information

12.1.2 Shanghai Shyndec Pharmaceutical Business Overview

12.1.3 Shanghai Shyndec Pharmaceutical Azithromycin API Product Models, Descriptions and Specifications

12.1.4 Shanghai Shyndec Pharmaceutical Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Shanghai Shyndec Pharmaceutical Azithromycin API Sales by Product in 2024

12.1.6 Shanghai Shyndec Pharmaceutical Azithromycin API Sales by Application in 2024

12.1.7 Shanghai Shyndec Pharmaceutical Azithromycin API Sales by Geographic Area in 2024

12.1.8 Shanghai Shyndec Pharmaceutical Azithromycin API SWOT Analysis

12.1.9 Shanghai Shyndec Pharmaceutical Recent Developments

12.2 Guobang Pharma

12.2.1 Guobang Pharma Corporation Information

12.2.2 Guobang Pharma Business Overview

12.2.3 Guobang Pharma Azithromycin API Product Models, Descriptions and Specifications

12.2.4 Guobang Pharma Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Guobang Pharma Azithromycin API Sales by Product in 2024

12.2.6 Guobang Pharma Azithromycin API Sales by Application in 2024

12.2.7 Guobang Pharma Azithromycin API Sales by Geographic Area in 2024

12.2.8 Guobang Pharma Azithromycin API SWOT Analysis

12.2.9 Guobang Pharma Recent Developments

12.3 CSPC Pharmaceutical Group

12.3.1 CSPC Pharmaceutical Group Corporation Information

12.3.2 CSPC Pharmaceutical Group Business Overview

12.3.3 CSPC Pharmaceutical Group Azithromycin API Product Models, Descriptions and Specifications

12.3.4 CSPC Pharmaceutical Group Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 CSPC Pharmaceutical Group Azithromycin API Sales by Product in 2024

12.3.6 CSPC Pharmaceutical Group Azithromycin API Sales by Application in 2024

12.3.7 CSPC Pharmaceutical Group Azithromycin API Sales by Geographic Area in 2024

12.3.8 CSPC Pharmaceutical Group Azithromycin API SWOT Analysis

12.3.9 CSPC Pharmaceutical Group Recent Developments

12.4 Nexchem Pharmaceutical

12.4.1 Nexchem Pharmaceutical Corporation Information

12.4.2 Nexchem Pharmaceutical Business Overview

12.4.3 Nexchem Pharmaceutical Azithromycin API Product Models, Descriptions and Specifications

12.4.4 Nexchem Pharmaceutical Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Nexchem Pharmaceutical Azithromycin API Sales by Product in 2024

12.4.6 Nexchem Pharmaceutical Azithromycin API Sales by Application in 2024

12.4.7 Nexchem Pharmaceutical Azithromycin API Sales by Geographic Area in 2024

12.4.8 Nexchem Pharmaceutical Azithromycin API SWOT Analysis

12.4.9 Nexchem Pharmaceutical Recent Developments

12.5 HEC Pharma

12.5.1 HEC Pharma Corporation Information

12.5.2 HEC Pharma Business Overview

12.5.3 HEC Pharma Azithromycin API Product Models, Descriptions and Specifications

12.5.4 HEC Pharma Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 HEC Pharma Azithromycin API Sales by Product in 2024

12.5.6 HEC Pharma Azithromycin API Sales by Application in 2024

12.5.7 HEC Pharma Azithromycin API Sales by Geographic Area in 2024

12.5.8 HEC Pharma Azithromycin API SWOT Analysis

12.5.9 HEC Pharma Recent Developments

12.6 Ningxia Qiyuan Pharmaceutical

12.6.1 Ningxia Qiyuan Pharmaceutical Corporation Information

12.6.2 Ningxia Qiyuan Pharmaceutical Business Overview

12.6.3 Ningxia Qiyuan Pharmaceutical Azithromycin API Product Models, Descriptions and Specifications

12.6.4 Ningxia Qiyuan Pharmaceutical Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Ningxia Qiyuan Pharmaceutical Recent Developments

12.7 Teva

12.7.1 Teva Corporation Information

12.7.2 Teva Business Overview

12.7.3 Teva Azithromycin API Product Models, Descriptions and Specifications

12.7.4 Teva Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Teva Recent Developments

12.8 Atom Pharma

12.8.1 Atom Pharma Corporation Information

12.8.2 Atom Pharma Business Overview

12.8.3 Atom Pharma Azithromycin API Product Models, Descriptions and Specifications

12.8.4 Atom Pharma Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Atom Pharma Recent Developments

12.9 Century Pharmaceuticals

12.9.1 Century Pharmaceuticals Corporation Information

12.9.2 Century Pharmaceuticals Business Overview

12.9.3 Century Pharmaceuticals Azithromycin API Product Models, Descriptions and Specifications

12.9.4 Century Pharmaceuticals Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Century Pharmaceuticals Recent Developments

12.10 Anuh Pharma Ltd

12.10.1 Anuh Pharma Ltd Corporation Information

12.10.2 Anuh Pharma Ltd Business Overview

12.10.3 Anuh Pharma Ltd Azithromycin API Product Models, Descriptions and Specifications

12.10.4 Anuh Pharma Ltd Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Anuh Pharma Ltd Recent Developments

12.11 Jubilant Pharmova Limite

12.11.1 Jubilant Pharmova Limite Corporation Information

12.11.2 Jubilant Pharmova Limite Business Overview

12.11.3 Jubilant Pharmova Limite Azithromycin API Product Models, Descriptions and Specifications

12.11.4 Jubilant Pharmova Limite Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Jubilant Pharmova Limite Recent Developments

12.12 Vadsp Pharmaceuticals

12.12.1 Vadsp Pharmaceuticals Corporation Information

12.12.2 Vadsp Pharmaceuticals Business Overview

12.12.3 Vadsp Pharmaceuticals Azithromycin API Product Models, Descriptions and Specifications

12.12.4 Vadsp Pharmaceuticals Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Vadsp Pharmaceuticals Recent Developments

12.13 Mehta Pharmaceutical

12.13.1 Mehta Pharmaceutical Corporation Information

12.13.2 Mehta Pharmaceutical Business Overview

12.13.3 Mehta Pharmaceutical Azithromycin API Product Models, Descriptions and Specifications

12.13.4 Mehta Pharmaceutical Azithromycin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Mehta Pharmaceutical Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Azithromycin API Industry Chain

13.2 Azithromycin API Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Azithromycin API Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Azithromycin API Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Azithromycin API Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Azithromycin API Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

Shanghai Shyndec Pharmaceutical

Guobang Pharma

CSPC Pharmaceutical Group

Nexchem Pharmaceutical

Ningxia Qiyuan Pharmaceutical

Jubilant Pharmova Limite

Vadsp Pharmaceuticals

Mehta Pharmaceutical

List of Tables

Table 1. Global Azithromycin API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Azithromycin API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Azithromycin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Azithromycin API Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Azithromycin API Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Azithromycin API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global Azithromycin API Sales by Region (2020-2025) & (Tons)

Table 8. Global Azithromycin API Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Azithromycin API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global Azithromycin API Production by Region (2020-2025) & (Tons)

Table 12. Global Azithromycin API Production by Region (2026-2031) & (Tons)

Table 13. Global Azithromycin API Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global Azithromycin API Sales Share by Manufacturers (2020-2025)

Table 15. Global Azithromycin API Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Azithromycin API Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Azithromycin API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azithromycin API as of 2024)

Table 19. Global Azithromycin API Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Azithromycin API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers Azithromycin API Manufacturing Base and Headquarters

Table 22. Global Azithromycin API Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Azithromycin API Sales by Type (2020-2025) & (Tons)

Table 26. Global Azithromycin API Sales by Type (2026-2031) & (Tons)

Table 27. Global Azithromycin API Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Azithromycin API Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Azithromycin API ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Azithromycin API Sales by Application (2020-2025) & (Tons)

Table 32. Global Azithromycin API Sales by Application (2026-2031) & (Tons)

Table 33. Azithromycin API High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Azithromycin API Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Azithromycin API Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Azithromycin API ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Azithromycin API Growth Accelerators and Market Barriers

Table 40. North America Azithromycin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Azithromycin API Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Azithromycin API Growth Accelerators and Market Barriers

Table 43. Europe Azithromycin API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Azithromycin API Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Azithromycin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Azithromycin API Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Azithromycin API Growth Accelerators and Market Barriers

Table 48. Southeast Asia Azithromycin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Azithromycin API Investment Opportunities and Key Challenges

Table 50. Central and South America Azithromycin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Azithromycin API Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Azithromycin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Shanghai Shyndec Pharmaceutical Corporation Information

Table 54. Shanghai Shyndec Pharmaceutical Description and Major Businesses

Table 55. Shanghai Shyndec Pharmaceutical Product Models, Descriptions and Specifications

Table 56. Shanghai Shyndec Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Shanghai Shyndec Pharmaceutical Sales Value Proportion by Product in 2024

Table 58. Shanghai Shyndec Pharmaceutical Sales Value Proportion by Application in 2024

Table 59. Shanghai Shyndec Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 60. Shanghai Shyndec Pharmaceutical Azithromycin API SWOT Analysis

Table 61. Shanghai Shyndec Pharmaceutical Recent Developments

Table 62. Guobang Pharma Corporation Information

Table 63. Guobang Pharma Description and Major Businesses

Table 64. Guobang Pharma Product Models, Descriptions and Specifications

Table 65. Guobang Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Guobang Pharma Sales Value Proportion by Product in 2024

Table 67. Guobang Pharma Sales Value Proportion by Application in 2024

Table 68. Guobang Pharma Sales Value Proportion by Geographic Area in 2024

Table 69. Guobang Pharma Azithromycin API SWOT Analysis

Table 70. Guobang Pharma Recent Developments

Table 71. CSPC Pharmaceutical Group Corporation Information

Table 72. CSPC Pharmaceutical Group Description and Major Businesses

Table 73. CSPC Pharmaceutical Group Product Models, Descriptions and Specifications

Table 74. CSPC Pharmaceutical Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. CSPC Pharmaceutical Group Sales Value Proportion by Product in 2024

Table 76. CSPC Pharmaceutical Group Sales Value Proportion by Application in 2024

Table 77. CSPC Pharmaceutical Group Sales Value Proportion by Geographic Area in 2024

Table 78. CSPC Pharmaceutical Group Azithromycin API SWOT Analysis

Table 79. CSPC Pharmaceutical Group Recent Developments

Table 80. Nexchem Pharmaceutical Corporation Information

Table 81. Nexchem Pharmaceutical Description and Major Businesses

Table 82. Nexchem Pharmaceutical Product Models, Descriptions and Specifications

Table 83. Nexchem Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Nexchem Pharmaceutical Sales Value Proportion by Product in 2024

Table 85. Nexchem Pharmaceutical Sales Value Proportion by Application in 2024

Table 86. Nexchem Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 87. Nexchem Pharmaceutical Azithromycin API SWOT Analysis

Table 88. Nexchem Pharmaceutical Recent Developments

Table 89. HEC Pharma Corporation Information

Table 90. HEC Pharma Description and Major Businesses

Table 91. HEC Pharma Product Models, Descriptions and Specifications

Table 92. HEC Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. HEC Pharma Sales Value Proportion by Product in 2024

Table 94. HEC Pharma Sales Value Proportion by Application in 2024

Table 95. HEC Pharma Sales Value Proportion by Geographic Area in 2024

Table 96. HEC Pharma Azithromycin API SWOT Analysis

Table 97. HEC Pharma Recent Developments

Table 98. Ningxia Qiyuan Pharmaceutical Corporation Information

Table 99. Ningxia Qiyuan Pharmaceutical Description and Major Businesses

Table 100. Ningxia Qiyuan Pharmaceutical Product Models, Descriptions and Specifications

Table 101. Ningxia Qiyuan Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Ningxia Qiyuan Pharmaceutical Recent Developments

Table 103. Teva Corporation Information

Table 104. Teva Description and Major Businesses

Table 105. Teva Product Models, Descriptions and Specifications

Table 106. Teva Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Teva Recent Developments

Table 108. Atom Pharma Corporation Information

Table 109. Atom Pharma Description and Major Businesses

Table 110. Atom Pharma Product Models, Descriptions and Specifications

Table 111. Atom Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. Atom Pharma Recent Developments

Table 113. Century Pharmaceuticals Corporation Information

Table 114. Century Pharmaceuticals Description and Major Businesses

Table 115. Century Pharmaceuticals Product Models, Descriptions and Specifications

Table 116. Century Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Century Pharmaceuticals Recent Developments

Table 118. Anuh Pharma Ltd Corporation Information

Table 119. Anuh Pharma Ltd Description and Major Businesses

Table 120. Anuh Pharma Ltd Product Models, Descriptions and Specifications

Table 121. Anuh Pharma Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. Anuh Pharma Ltd Recent Developments

Table 123. Jubilant Pharmova Limite Corporation Information

Table 124. Jubilant Pharmova Limite Description and Major Businesses

Table 125. Jubilant Pharmova Limite Product Models, Descriptions and Specifications

Table 126. Jubilant Pharmova Limite Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 127. Jubilant Pharmova Limite Recent Developments

Table 128. Vadsp Pharmaceuticals Corporation Information

Table 129. Vadsp Pharmaceuticals Description and Major Businesses

Table 130. Vadsp Pharmaceuticals Product Models, Descriptions and Specifications

Table 131. Vadsp Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 132. Vadsp Pharmaceuticals Recent Developments

Table 133. Mehta Pharmaceutical Corporation Information

Table 134. Mehta Pharmaceutical Description and Major Businesses

Table 135. Mehta Pharmaceutical Product Models, Descriptions and Specifications

Table 136. Mehta Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 137. Mehta Pharmaceutical Recent Developments

Table 138. Key Raw Materials Distribution

Table 139. Raw Materials Key Suppliers

Table 140. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 141. Milestones in Production Technology Evolution

Table 142. Distributors List

Table 143. Market Trends and Market Evolution

Table 144. Market Drivers and Opportunities

Table 145. Market Challenges, Risks, and Restraints

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Azithromycin API Product Picture

Figure 2. Global Azithromycin API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Azithromycin Dihydrate Product Picture

Figure 4. Azithromycin Monohydrate Product Picture

Figure 5. Global Azithromycin API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Tablet

Figure 7. Injection

Figure 8. Other

Figure 9. Azithromycin API Report Years Considered

Figure 10. Global Azithromycin API Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 12. Global Azithromycin API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Azithromycin API Revenue Market Share by Region (2020-2031)

Figure 14. Global Azithromycin API Sales (2020-2031) & (Tons)

Figure 15. Global Azithromycin API Sales (CAGR) by Region (2020-2031) (Tons)

Figure 16. Global Azithromycin API Sales Market Share by Region (2020-2031)

Figure 17. Global Azithromycin API Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 18. Global Azithromycin API Production Trend by Region (2020-2031) (Tons)

Figure 19. Global Azithromycin API Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Azithromycin API Production Growth Rate in North America (2020-2031) & (Tons)

Figure 22. Azithromycin API Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 23. Azithromycin API Production Growth Rate in China (2020-2031) & (Tons)

Figure 24. Azithromycin API Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 25. Top 5 and Top 10 Manufacturers Azithromycin API Sales Volume Market Share in 2024

Figure 26. Global Azithromycin API Revenue Market Share Ranking (2024)

Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 28. Azithromycin Dihydrate Revenue Market Share by Manufacturer in 2024

Figure 29. Azithromycin Monohydrate Revenue Market Share by Manufacturer in 2024

Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 32. Global Azithromycin API Sales Market Share by Type (2020-2031)

Figure 33. Global Azithromycin API Revenue Market Share by Type (2020-2031)

Figure 34. Global Azithromycin API Sales Market Share by Application (2020-2031)

Figure 35. Global Azithromycin API Revenue Market Share by Application (2020-2031)

Figure 36. North America Azithromycin API Sales YoY (2020-2031) & (Tons)

Figure 37. North America Azithromycin API Revenue YoY (2020-2031) & (US$ Million)

Figure 38. North America Top 5 Manufacturers Azithromycin API Sales Revenue (US$ Million) in 2024

Figure 39. North America Azithromycin API Sales Volume (Tons) by Type (2020- 2031)

Figure 40. North America Azithromycin API Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 41. North America Azithromycin API Sales Volume (Tons) by Application (2020-2031)

Figure 42. North America Azithromycin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. US Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 44. Canada Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 45. Mexico Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 46. Europe Azithromycin API Sales YoY (2020-2031) & (Tons)

Figure 47. Europe Azithromycin API Revenue YoY (2020-2031) & (US$ Million)

Figure 48. Europe Top 5 Manufacturers Azithromycin API Sales Revenue (US$ Million) in 2024

Figure 49. Europe Azithromycin API Sales Volume (Tons) by Type (2020-2031)

Figure 50. Europe Azithromycin API Sales Revenue (US$ Million) by Type (2020-2031)

Figure 51. Europe Azithromycin API Sales Volume (Tons) by Application (2020-2031)

Figure 52. Europe Azithromycin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 53. Germany Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 54. France Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 58. Asia-Pacific Azithromycin API Sales YoY (2020-2031) & (Tons)

Figure 59. Asia-Pacific Azithromycin API Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Top 8 Manufacturers Azithromycin API Sales Revenue (US$ Million) in 2024

Figure 61. Asia-Pacific Azithromycin API Sales Volume (Tons) by Type (2020- 2031)

Figure 62. Asia-Pacific Azithromycin API Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 63. Asia-Pacific Azithromycin API Sales Volume (Tons) by Application (2020-2031)

Figure 64. Asia-Pacific Azithromycin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 65. Indonesia Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 66. Japan Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 67. South Korea Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 68. China Taiwan Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 69. India Azithromycin API Revenue (2020-2031) & (US$ Million)

Figure 70. Central and South America Azithromycin API Sales YoY (2020-2031) & (Tons)

Figure 71. Central and South America Azithromycin API Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Central and South America Top 5 Manufacturers Azithromycin API Sales Revenue (US$ Million) in 2024

Figure 73. Central and South America Azithromycin API Sales Volume (Tons) by Type (2021-2031)

Figure 74. Central and South America Azithromycin API Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Central and South America Azithromycin API Sales Volume (Tons) by Application (2020-2031)

Figure 76. Central and South America Azithromycin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. Brazil Azithromycin API Revenue (2020-2025) & (US$ Million)

Figure 78. Argentina Azithromycin API Revenue (2020-2025) & (US$ Million)

Figure 79. Middle East, and Africa Azithromycin API Sales YoY (2020-2031) & (Tons)

Figure 80. Middle East and Africa Azithromycin API Revenue YoY (2020-2031) & (US$ Million)

Figure 81. Middle East and Africa Top 5 Manufacturers Azithromycin API Sales Revenue (US$ Million) in 2024

Figure 82. Middle East and Africa Azithromycin API Sales Volume (Tons) by Type (2021-2031)

Figure 83. South America Azithromycin API Sales Revenue (US$ Million) by Type (2020-2031)

Figure 84. Middle East and Africa Azithromycin API Sales Volume (Tons) by Application (2020-2031)

Figure 85. Middle East and Africa Azithromycin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 86. GCC Countries Azithromycin API Revenue (2020-2025) & (US$ Million)

Figure 87. Turkey Azithromycin API Revenue (2020-2025) & (US$ Million)

Figure 88. Egypt Azithromycin API Revenue (2020-2025) & (US$ Million)

Figure 89. South Africa Azithromycin API Revenue (2020-2025) & (US$ Million)

Figure 90. Azithromycin API Industry Chain Mapping

Figure 91. Regional Azithromycin API Manufacturing Base Distribution (%)

Figure 92. Azithromycin API Production Process

Figure 93. Regional Azithromycin API Production Cost Structure

Figure 94. Channels of Distribution (Direct Vs Distribution)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Azathioprine API Market Research Report 2025

Global Azithromycin Capsules Market Research Report 2024

Global Azithromycin Dihydrate Market Research Report 2025

Global Azathramycin Market Research Report 2024

Global Azithromycin Dispersible Tablet Market Research Report 2024

Global Polymyxin API Market Research Report 2024

Global Azvudine API Market Research Report 2025

Global Clotrimazole API Market Research Report 2024

Global Cinnarizine API Market Research Report 2025

Global Flurbiprofen API Market Research Report 2025

Global Azvudine Market Research Report 2024

Global Tetracycline API Market Research Report 2025

Global Acyclovir API Market Research Report 2025

Global Erythromycin API Market Research Report 2025

Global Aziridines Market Research Report 2024

Global Moxifloxacin API Market Research Report 2024

Methimazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global API Drug Development Service Market Research Report 2024

Global Thiothixene API Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions